Abstract
The study of submicroscopic or minimal residual disease (MRD) in childhood acute lymphoblastic leukemia may eventually lead to stratification of therapy on an individual patient basis (reviewed in ref. 1). PCR of immunoglobulin heavy chain (IgH) and T-cell receptor (TCR) gene rearrangements provides widely informative markers (Table 1), which, in the majority of cases, are stable during the disease course (2). Generation of leukemia-specific probes using this technique allows detection of MRD at levels of one leukemic cell in 10,000 to 100,000 normal bone marrow mononuclear cells (BM MNC).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Potter, M. N., Steward, C. G., Maitland, N., and Oakhill, A. (1993) The signiflcance of the detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 83, 1412–1418.
Steward, C. G., Goulden, N. J., Katz, F., Baines, D., Martin, P. G., Langlands, K., Potter, M. N., Chessells, J. M., and Oakhtll, A. (1994) A polymerase chain reaction study of the stability of immunoglobulin heavy chain and T-cell receptor d gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia Blood 83, 1355–1362
Steward, C G., Goulden, N. J., Potter, M. N., and Oakhill A. (1993) The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia. Eur J. Cancer 8, 1192–1198.
Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S. S., Lange, B., Tsujimoto, Y., Caton, A. J., and Rovera, G. (1989) Detectton of minimal disease in haemopoetic malignancies of the B-cell lineage by using third-comple-mentarity-determiningregion (CDR-III)-specific probes Proc. Natl. Acad Scz USA 86, 5123–5127
Yokota, S., Hansen-Hagge, T. E., Ludwig, W D., Reiter, A., Raghavachar, A., Kleihauer, E., and Bartram, C. R (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukaemia patients Blood 77, 331–339
Brisco, M. J., Tan, L W, Osborn, A. M., and Morley, A. A. (1990) Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 75, 163–167.
Murray, V. (1989) Improved double-stranded DNA sequencing using the linear polymerase chain reaction Nucleic Acids Res 17, 8889.
Kwok, S. and Higuchi, R (1989) Avoiding false positives with PCR Nature 339, 237–238.
Nizet, Y., Van Daele, S, Lewalle, P., Vaerman, J. L., Philippe, M., Vermylen, C, Cornu, G., Ferrant, A, Michaux, J. L., and Martiat, P. (1994) Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogenic IgH probes and the polymerase chain reaction. Blood 82, 1618–1625
Langlands, K., Goulden, N J, Steward, C. G., Potter, M N., Cornish, J. M., and Oakhill, A (1994) False positive residual disease assessment post-bone marrow transplant in acute lymphoblastic leukaemta. Blood 84, 1352,1353 (letter)
Sambrook, J., Fritch, E. F., and Mamans, T(1989) Molecular Cloning A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Goulden, N., Langlands, K., Steward, C., Knechtli, C., Potter, M., Oakhill, T. (1996). PCR of Gene Rearrangements for the Detection of Minimal Residual Disease in Childhood ALL. In: Cotter, F.E. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine™, vol 6. Humana Press. https://doi.org/10.1385/0-89603-341-4:3
Download citation
DOI: https://doi.org/10.1385/0-89603-341-4:3
Publisher Name: Humana Press
Print ISBN: 978-0-89603-341-2
Online ISBN: 978-1-59259-590-7
eBook Packages: Springer Protocols